返回ChemicalBook首页>CAS数据库列表>892711-75-0

892711-75-0

中文名称 4-异丙氧基-N-(2-甲基喹啉-8-基)苯甲酰胺
英文名称 CDN 1163
CAS 892711-75-0
分子式 C20H20N2O2
分子量 320.39
MOL 文件 892711-75-0.mol
更新日期 2023/03/20 15:41:25
892711-75-0 结构式 892711-75-0 结构式

基本信息

中文别名
化合物CDN1163
4-异丙氧基-N-(2-甲基喹啉-8-基)苯甲酰胺
英文别名
CDN1163
4-isopropoxy-N-(2-methylquinolin-8-yl)benzamide
N-(2-methylquinolin-8-yl)-4-propan-2-yloxybenzamide
4-(1-Methylethoxy)-N-(2-methyl-8-quinolinyl)benzamide
Benzamide, 4-(1-methylethoxy)-N-(2-methyl-8-quinolinyl)-
Inhibitor,CDN 1163,Calcium Channel,Ca channels,Ca2+ channels,CDN-1163,CDN1163,inhibit
所属类别
生物化工:生化试剂

物理化学性质

熔点87 - 89°C
储存条件2-8°C
溶解度溶于DMSO(>25mg/ml)
形态粉末
颜色白色至米色
稳定性Stable for 1 year as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.

安全数据

危险性符号(GHS)
GHS07
警示词警告
危险性描述H302-H315-H319-H335
4-异丙氧基-N-(2-甲基喹啉-8-基)苯甲酰胺价格(试剂级)
报价日期产品编号产品名称CAS号包装价格
2024/04/30HY-1014554-异丙氧基-N-(2-甲基喹啉-8-基)苯甲酰胺
CDN1163
892711-75-05mg770元
2024/04/30HY-1014554-异丙氧基-N-(2-甲基喹啉-8-基)苯甲酰胺
CDN1163
892711-75-010mM * 1mLin DMSO847元
2024/04/30HY-1014554-异丙氧基-N-(2-甲基喹啉-8-基)苯甲酰胺
CDN1163
892711-75-010mg1250元

常见问题列表

生物活性
CDN1163是一种 sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 的小分子变构激活剂,可改善 Ca2+ 稳态。
靶点
TargetValue
SERCA
()
体外研究

CDN1163 (5.5-25 mM; 0-8 hours; rat cardiac myocyte cells) treatment reduces high glucose-induced resistin and nuclear NFATc expression and increases the phosphorylation of AMPKα in a time-dependent manner.

Western Blot Analysis

Cell Line: Rat cardiac myocyte cells (H9c2)
Concentration: 5.5 mM, 25 mM
Incubation Time: 0 hour, 4 hours, 8 hours
Result: High glucose-induced resistin and nuclear NFATc expression were significantly reduced. The phosphorylation of AMPKα is increased in a time-dependent manner.
体内研究

CDN1163 (50 mg/kg; intraperitoneal injection; for 5 days; male ob/ob mice and lean ob/+ mice) increases SERCA2 Ca 2+ -ATPase activity, decreases endoplasmic reticulum (ER) stress-induced cell death in vitro and improves liver Ca 2+ transport activity. CDN1163 reduces blood glucose levels and improves metabolic parameters and gluconeogenic gene expression, reverses hepatic steatosis, inhibits ER stress and ER stress-induced apoptosis, and improves mitochondrial efficiency in ob/ob mice in vivo.

Animal Model: Male 8-10-week old ob/ob mice and lean ob/+ mice
Dosage: 50 mg/kg
Administration: Intraperitoneal injection; for 5 days
Result: Markedly lowered fasting blood glucose, improved glucose tolerance, and ameliorated hepatosteatosis but did not alter glucose levels or body weight. Increased expression of uncoupling protein 1 (UCP1) and UCP3 in brown adipose tissue and reduced the hepatic expression of genes involved in gluconeogenesis and lipogenesis, attenuated ER stress response and ER stress-induced apoptosis, and improved mitochondrial biogenesis, possibly through SERCA2-mediated activation of AMP-activated protein kinase pathway.
"892711-75-0" 相关产品信息
57444-62-9 53092-52-7 1146618-41-8